Exane Derivatives’s DBV Technologies DBVT Stock Holding History

Exane Derivatives’s Portfolio DBVT Stock Details DBVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$258	Hold	10	–	–	﹤0.01%	652
2022 Q1	$161	Hold	10	–	–	﹤0.01%	974
2021 Q4	$162	Hold	10	–	–	﹤0.01%	849
2021 Q3	$495	Hold	10	–	–	﹤0.01%	939
2021 Q2	$529	Hold	10	–	–	﹤0.01%	937
2021 Q1	$538	Sell	10 -190	-95%	-$10.1K	﹤0.01%	792
2020 Q4	$5.24K	Buy	200 +116	+138%	+$2.57K	﹤0.01%	557
2020 Q3	$1.45K	Sell	84 -1,216	-94%	-$34.9K	﹤0.01%	589
2020 Q2	$57.1K	Hold	1,300	–	–	0.02%	343
2020 Q1	$51K	Buy	+1,300	New	+$117K	0.01%	350

Other funds holding DBVT

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

NFGH

Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Exane Derivatives's DBVT Position: Q2 2022 in Review

Exane Derivatives held its DBV Technologies (DBVT) position steady in Q2 2022 at 10 shares worth $258. The position accounts for ﹤0.01% of the portfolio, ranked #652.

Exane Derivatives first reported a position in DBVT in Q1 2020 and has held it in 10 quarters since. The position peaked at $57.1K in Q2 2020. 38 funds tracked by Wall St. Rank hold DBVT as of Q2 2022.

Exane Derivatives held 10 shares of DBV Technologies worth $258 as of Q2 2022.
Exane Derivatives left its DBV Technologies share count unchanged in Q2 2022.
DBV Technologies made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #652 holding.
Exane Derivatives first reported a position in DBV Technologies in Q1 2020 and has held it in 10 quarters since.
Exane Derivatives's DBV Technologies position peaked at $57.1K in Q2 2020.
38 funds tracked by Wall St. Rank held DBV Technologies as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.